Assessment of the current Medicare reimbursement system for breast cancer operations

Annals of Surgical Oncology

Volumn 11, Issue 12, 2004, Pages 1037-1044

  Lucci, Anthony ^a,c   Shoher, Angela ^a   Sherman, Marc O ^b   Azzizadeh, Ali ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b Hematol Oncol Assoc of Houston   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer; Breast operations; Medicare; Outcomes; Reimbursement

Indexed keywords

ANALGESIC AGENT;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER PATIENT; CORRELATION ANALYSIS; DATA ANALYSIS; FOLLOW UP; HOSPITAL COST; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICARE; PAIN; PARESTHESIA; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; REIMBURSEMENT; SEGMENTAL MASTECTOMY; WORK; AGED; BREAST TUMOR; ECONOMICS; FEE; FEMALE; MASTECTOMY; PATIENT CARE PLANNING; TREATMENT OUTCOME; UNITED STATES;

AGED; BREAST NEOPLASMS; FEE SCHEDULES; FEMALE; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MASTECTOMY; MASTECTOMY, SEGMENTAL; MEDICARE; PATIENT CARE PLANNING; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES;

EID: 16644394623     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2004.03.034     Document Type: Article

References (24)

1. van Dongen JA, Bartelink H, Fentiman IS, et al. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 1992;28A:801-5.
2. Veronesi U, Saccozzi R, Del Vecchio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 1981;305:6-11.
3. Sarrazin D, Le MG, Arriagada R, et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 1989;14:177-84.
4. Lichter AS, Lippman ME, Danforth DN Jr, et al. Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. J Clin Oncol 1992;10:976-83.
5. Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989;320:822-8.
6. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
7. Blichert-Toft M, Brincker H, Andersen JA, et al. A Danish randomized trial comparing breast-preserving therapy with mastectomy in mammary carcinoma. Preliminary results. Acta Oncol 1988;27:671-7.
8. Centers for Medicare and Medicaid Services. http://www.cms.hhs.gov/ physicians/mpfsapp/step0.asp.
9. Giuliano AE. See one, do twenty-five, teach one: the implementation of sentinel node dissection in breast cancer. Ann Surg Oncol 1999;6:520-1.
10. Simmons RM. Review of sentinel lymph node credentialing: how many cases are enough? J Am Coll Surg 2001;193:206-9.
11. McMasters KM, Wong SL, Chao C, et al. Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques. Ann Surg 2001;234:292-9; discussion, 299-300.
12. Kane JM 3rd, Edge SB, Winston JS, et al. Intraoperative pathologic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection. Ann Surg Oncol 2001;8:361-7.
13. Rubio IT, Korourian S, Cowan C, et al. Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol 1998;5:689-94.
14. The American Society of Breast Surgeons. www.breastsurgeons.com.
15. Hadley J, Mandelblatt JS, Mitchell JM, et al. Medicare breast surgery fees and treatment received by older women with localized breast cancer. Health Serv Res 2003;38:553-73.
16. Howisey RL, Acheson MB, Rowbotham RK, et al. A comparison of Medicare reimbursement and results for various imaging-guided breast biopsy techniques. Am J Surg 1997;173:395-8.
17. McKee MD, Cropp MD, Hyland A, et al. Provider case volume and outcome in the evaluation and treatment of patients with mammogram-detected breast carcinoma. Cancer 2002;95:704-12.
18. Osteen RT, Karnell LH. The National Cancer Data Base report on breast cancer. Cancer 1994;73:1994-2000.
19. Morrow M, White J, Moughan J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol 2001;19:2254-62.
20. Locker GSR, Cuzick J. Breast surgery in the ATAC trial: women from the United States are more likely to have mastectomy. Breast Cancer Res Treatment 2002;76:S27.
21. Lee-Feldstein A, Feldstein PJ, Buchmueller T, et al. Breast cancer outcomes among older women: HMO, fee-for-service, and delivery system comparisons. J Gen Intern Med 2001;16:189-99.
22. Michalski TA, Nattinger AB. The influence of black race and socioeconomic status on the use of breast-conserving surgery for Medicare beneficiaries. Cancer 1997;79:314-9.
23. Lee-Feldstein A, Anton-Culver H, Feldstein PJ. Treatment differences and other prognostic factors related to breast cancer survival. Delivery systems and medical outcomes. JAMA 1994;271:1163-8.
24. Roetzheim RG, Gonzalez EC, Ferrante JM, et al. Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer 2000;89:2202-13.